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Smoking had been increasing the risk factor of type 2 diabetes mellitus (T2DM), both active and 
passive smokers, which is caused by nicotine contained in cigarettes. Nicotine has metabolized by 
cytochrome p450 2a6 (CYP2A6) enzyme coded by the CYP2A6 gene. This gene was a high 
polymorphism that is the CYP2A6*4 allele gene was inactive. Thus, our objective was to describe the 
CYP2A6*4 allele gene among active and passive Javanese smokers with T2DM. From this cross-
sectional study, we identified this allele gene among 46 of the adults with T2DM, which were consist 
of 23 active smokers and 23 passive smokers. The CYP2A6*4 allele gene identification has done 
using polymerase chain reaction (PCR) methods. The CYP2A6*4 allele frequency was analyzed to 
describe the distribution of this allele among the participants. This study supports the hypothesis that 
smoking, including cigarette smoke, was an environmentally modifiable risk factor for developing 
T2DM. Based on our result, the allele frequency among the participants was 42.39%. A high 
frequency of the CYP2A4 allele gene among the participants was indicating that the CYP2A4 allele 
gene was also the other risk factor in developing T2DM. 
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As stated by the American Diabetes Association (Association, 2011), diabetes mellitus was one 
of the metabolic diseases characterizing by hyperglycemia that appears due to malfunctions of insulin 
secretion, insulin resistance, or both. It is a chronic disease that refers to the body's inability to 
metabolize carbohydrates, fats, and proteins. Furthermore, this condition was leading to 
hyperglycemia. Diabetes mellitus disease has been considering to be a disease found in adults.  
Nevertheless, in the past 20 years, it has been an increase in the prevalence of diabetes in children and 
young people. As reported in Indonesia's Primary Health Research (R.I., 2018b), known as Riskesdas, 
Diabetes Mellitus prevalence in Indonesia has increased from 6.9% in 2013 to 8.5% in 2018. 
Diabetes is one of the underdiagnosed diseases. It has been estimating that 30% of people who 
suffered from it are often unaware of this disease. Moreover, approximately 25% of them have had 
microvascular complications after being diagnosed with T2DM. The most common type of diabetes 
found among adults was type 2 diabetes mellitus (T2DM). It has been estimating that more than 90% 
of all diabetes cases are T2DM. The prevalence of diabetes mellitus in urban Indonesia was 6.2%. 
Some researchers predicted more than half of diabetes cases in Indonesia were not diagnosed, 
especially among young people. According to the International Diabetes Federation (IDF), in 2017, 
163 million people in Indonesia have been living with T2DM; by 2045, this will rise to 212 million. 
T2DM was also commonly known as the silent killer disease. At first, people living with T2DM 
frequently have no symptoms and were usually detected after the age of 40 years or more. However, it 
was also possible that someone was getting T2DM before the age of 40 years.  Once a person has been 
diagnosed with T2DM, it gradually can affect all the body organs. Furthermore, it would cause various 
damage and dysfunction of several organs, especially the eyes, kidneys, nerves, heart, and blood 
vessels. T2DM development has been relating to several risk factors, such as age, ethnicity, obesity, 
family history, physical activity, lifestyle behavior, and cigarette smoking. Some studies suggest that 
poor smoking behavior has been associating with chronic complications of T2DM compared to 
nonsmokers (Hilawe et al., 2015; Hong et al., 2018; Kowall et al., 2010; Liu et al., 2018; Nilsson et al., 
2014). Nicotine, the main bioactive compound contained both in cigarettes and tobacco smokes, was 
considered as the most accountable for increasing blood glucose levels (Bajaj, 2012; Borowitz and 
Isom, 2008; Xie et al.,  2009).   
Nicotine was inactivated to cotinine by CYP2A6, an enzyme coded by the CYP2A6. The 
CYP2A6 gene was highly polymorphic and had detected among various ethnicities who are indicating 
by a broad interethnic variability smoking behavior of the allele carrying persons. The wild-type allele 
was CYP2A6*1, the whole gene deletion that causing loss of enzymatic activity was CYP2A6*4. This 
gene was frequently found in the Asian population and corresponded to both slow and poor nicotine 
metabolizers (Tanner and Tyndale, 2017). Thus, slow and poor nicotine metabolizers will inactivate 
nicotine more slowly than normal metabolizers. It is leading to a high risk of developing diabetes. 
Indonesia was one of the countries with a high level of cigarette consumption (Barber et 
al.,2008). To date, public awareness of the smoking risks in Indonesia still has no attention yet 
including diabetes risk among smokers. Both smoking and diabetes could damage body cells and 
organs. Smokers living with diabetes have higher risks for severe health problems, including 
cardiovascular and kidney disease, retinopathy, and peripheral neuropathy (Campagna et al., 2019). In 
our previous study, we revealed that there was a highly frequent CYP2A6*4 among Javanese Smokers 
and they were identified as nicotine slow metabolizers (Patramurti et al., 2015). Therefore, in this 
study, we learned the allele frequencies of the CYP2A6*4 genes among T2MD patients to describe the 
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MATERIALS AND METHODS  
Materials 
The Ron's Blood and Cell DNA Mini Kit reagents were obtained from Bioron GmbH 
(Germany). Go Taq Green Master Mix contained Taq DNA polymerase, 400µM dATP, 400µM dGTP, 
400µM dCTP, 400µM dTTP, 3 mM MgCL2, Buffer (pH 8.5), and Nuclease-Free Water obtained from 
Promega Corporation (USA). AccuBandTM 100 bp+3K DNA Ladder II obtained from SMOBIO 




This research was carried out in five Primary Health Care, known as Puskesmas, located in 
Sleman Regency, Special Region of Yogyakarta. It is an observational study with cross-sectional 
design and purposive sampling. The study population was patients, who had the same symptoms 
associated with diabetes, including polyuria, polydipsia, polyphagia, and tiredness. They were men, 
and women, aged 30-80 years and visited the five Puskesmas above during April-June 2020. Base on 
their symptoms, the baseline clinical trial was done, including assessment of random plasma glucose, 
fasting glucose levels, HbA1c levels, and completion of questionnaires. 
A standard questionnaire to each participant has been using to obtain information about 
demographics, socioeconomic status, smoking habits, physical activity, and medical history. Smoking 
status has been classifying into two categories. It was never and current smokers. Some questions were 
collected to find out information about smoking status, including age at starting and quitting smoking, 
type of tobacco, the number of cigarettes smoked per day (CPD), and duration of cigarette smoking 
(Heatherton et al., 1991). 
A standard questionnaire to each participant has been using to obtain Only participants who 
have filled out the questionnaire and signed informed consent were eligible to participate in this study. 
The study has approved by the Ethics Committees of Medical Research Duta Wacana University 
(Yogyakarta, Indonesia) with ethical clearance No. 1199/C.16/FK/2020. All data collected was 
confidential because these documents have managed anonymously, so these data collected could not 
be recognized. 
Blood samples were taken from the subject veins and collected in a vacutainer containing 
EDTA (1.8 mg / mL blood). The blood samples have used as a material for DNA isolation using Ron's 
Blood and Cell DNA Mini Kit reagents. The polymerase chain reaction (PCR) method has been using 
to analyze the CYP2A6*4 allele gene in isolated DNA. The sequence of the PCR primer forward: 5'-
CCT CAT CAC ACA CAA CTT CCT C-3’; reverse primer (wild type): 5'-CGC AGG TAC TGG 
GTG CTT GGT AG-3'; (mutant):  5'-TGC AGG TAC TGG GTG CTT GGT AG-3']. 
A reaction solution of 25 μL contained Promega Go Taq Green Master Mix (12.5 μL), forward 
primer (1.25 μL), reverse primer (1.25 μL), isolated DNA (5.0 μL), and Nuclease-free Water (5.0 μL). 
The PCR analysis carried out under the following conditions: after initial denaturation at 95 °C for 5 
min, 30 cycles of denaturation at 98 °C for 20 sec, annealing at 64 °C for 15 sec, and extension at 
72°C for 30 sec were performing. Finally, the reaction was finished by a final extension at 72 °C for 5 
min. The 3.0 μL of the amplified PCR product was identified by electrophoresis on 1.5% agarose gel 
and documented using a Polaroid camera. The PCR products of CYP2A6*1 and CYP2A*4 allele gene 
were detected at 350-bp.  
 
Data Analysis 
The 95% confidence intervals were calculated for all observed allele frequencies. The Hardy–
Weinberg equation was used to calculate the expected genotype frequencies from the allele frequency 
among the participants (p2 + 2pq + q2 = 1). The qualitative analysis was used to illustrate the effect of 
CPY2A6 polymorphism, CYP2A6*1 and CYP2A6*4 alleles, on T2DM risk factor among the 
subjects. 
 
                ISSN: 2088 4559; e-ISSN: 2477 0256 






RESULT AND DISCUSION 
Today, Indonesia was undergoing a pattern changing in diseases that are often called 
epidemiological transitions marked by increased mortality and illness due to non-communicable 
diseases (PTM) such as stroke, heart disease, diabetes, and others. This study aimed to evaluate the 
effect of CYP2A6 polymorphism, especially the CYP2A6*4 allele gene and smoking behavior on the 
risk of T2DM among diabetic patients in primary health care, known as Puskesmas, located in Sleman 
Regency, Special Region of Yogyakarta. It is an observational study using a cross-sectional design. 
The subjects participating in this study were T2DM patients from those five Puskesmas. This T2DM 
disease was the seventh leading of ten non-communicable diseases commonly suffered by people in 
this regency. It has been estimating that 29,079 cases of diabetes patients have been founding in this 
area (R.I., 2018b).  
All the subjects participating in this study were new patients who have never been diagnosed 
with diabetes. They have been recruiting from April-June 2020. Early identification for each subject 
has been determined based on their symptoms that are leading to diabetes. They are polyuria, 
polydipsia, polyphagia, and tiredness.  Further assessments have been carrying out to establish the 
diagnosis. The examination of random plasma glucose and HbA1c levels has been carrying out to 
establish the diagnosis. We defined participants as having T2DM if they met the following criteria: the 
blood fasting glucose level was more than 125 mg/dL, and the HbA1c concentration was more than 
6.5 (ADA, 2014). Based on these examinations, a total of 75 patients were diagnosed with T2DM, 
which are consisting of 52 females and 23 males. Based on this data, there were saw those female 
sufferers were greater than males. It was in line with documents presented in Riskesdas (R.I., 2018b), 
which was the number of Indonesian females living with T2DM was greater (1.8%) than males 
(1.2%). Some other studies have also revealed that females have a higher risk of developing diabetes 
than males.  It was due to the female’s physical activity was lower than in males, resulting in body fat 
accumulation that triggers obesity (Abdullah and Mansour, 2020; Agbogli and Annan, 2017; Asiimwe 
et al., 2020; Eze et al., 2014). Furthermore, it is associated with an enhanced risk of developing insulin 
resistance and ultimately causing the T2DM (Mary et al., 2014). The other risk factors are age, T2DM 
family history, physical activity, and smoking behavior. 
Of the total 75 patients suffering from T2DM, 46 patients have been recruiting to participate in 
this study, consist of 23 subjects who were active smokers and 23 who were passive smokers. 
Therefore, to investigate more information about the participants, they were given several questions 
related to diseases and smoking behavior. Several studies have shown that a family history of diabetes 
was one of the main risk factors for a person developing T2DM (Cederberg and Stan, 2014; Sakurai et 
al., 2013; Scott et al., 2014; Zhao et al., 2017). Some studies have also suggested that smoking 
behavior could increase the T2DM risk factors, neither active nor passive smokers (Hackethal, 2015; 
Hong et al., 2018; Kowall et al., 2010; Liu et al., 2018; Nilsson et al., 2014; Yeh et al., 2010). The 
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Age           
< 45 1 4.3 2 8.7 6.5 
> 45 22 95.7 21 91.3 93.5 
 Smoking status 
     Smokers 23 100.0 0 0.0 50.0 
Non Smokers 0 0.0 23 100.0 50.0 
 Smoking years 
     < 25 3 13.0 0 0.0 13.0 
> 25 20 87.0 0 0.0 87.0 
 CPD 
     < 10 4 17.4 0 0.0 17.4 
11 - 20 17 73.9 0 0.0 73.9 
21 - 30 2 8.7 0 0.0 8.7 
 Family History 6 26.1 7 30.4 28.3 
No Family History 17 73.9 16 69.6 71.7 
 
Age was also a risk factor for someone developing T2DM. The American Diabetes Association 
(ADA) suggests annual diabetes screening tests after people reach 45 years of age. Based on Table 1 
above, 93.5% of the subjects were more than 45 years old, and only 6.5% of patients had aged less 
than 45 years. Several studies have shown that the possibility of developing the T2DM increases 
significantly after 45 years of age (Alva et al.,2017; Kirkman et al.,2012; Nguyen et al., 2012; Sattar et 
al., 2019). Primary Health Research Indonesia has reported that T2DM accounted for 90-95 percent of 
diagnoses of diabetic adults in Indonesia, with the largest number of T2DM sufferers are aged range 
55-64 years and 65-74 years. It has been estimating 30% population in Indonesia has lived with 
diabetes, and 25% of those people have suffered a microvascular complication (R.I., 2018b). The 
T2DM was one of the underdiagnosed diseases.  It commonly goes undiagnosed for several years 
because hyperglycemia grows slowly, and at initial periods it was frequently not severe enough for the 
patient to detect the common T2DM symptoms. Moreover,  the average delay from onset to diagnosis 
was estimated to be 7th years (Buell et al., 2007).  
Table 1 shows that 71.7% of the subjects did not have a family history of diabetes. It indicates 
that the development of diabetes in patients has been mainly causing by the environment or their 
lifestyle, including physical activity and smoking behavior. Several studies have shown that being 
physically inactive will lead to being overweight, which is a trigger for diabetes risk factors (Binh and 
Nhung, 2015; Cornier et al., 2005; Hu, 2011; Liu et al., 2000; Schulze et al., 2015). The other studies 
have revealed that smoking activity, an environmental factor, have also increased the risk of incident 
T2DM (Hackethal, 2015; Hong et al., 2018; Jee et al., 2010; Liu et al., 2018).  
In this study, all the smokers were male, while all the non-smokers were female. There have 
been estimating that 68.1% of active smokers in Indonesia were adult males (Zheng et al., 2018). 
There have been estimating that 96 million women and children in Indonesia are passive smokers who 
have been routinely exposing to secondhand smoke (Barber et al., 2008; R.I., 2018a). Some other 
studies have shown that passive smokers also have a high risk for developing T2DM even in those 
who are never themselves active smokers (Eze et al., 2014; Wang et al., 2013; Wei et al., 2014). 
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Therefore a high percentage of subjects did not have a T2DM family history in this study might also 
be caused that they are passive smokers. Hackethal (2015) has indicated that active smokers had a 
37% increased risk for T2DM, otherwise former smokers had a 14% increased risk, and people who 
have been exposing to secondhand smoke had a 22% higher risk for developing T2DM.  
In the previous study, we revealed that smoking behavior could affect glycohemoglobin levels 
(HbA1c) (Patramurti and Fenty, 2020). There has been demonstrating that the number of cigarettes 
smoked, and the length of smoking activity will increase the HbA1c level that leading to a high risk 
for suffering T2DM. Smoking more than 20 cigarettes a day almost doubles a smoker's odds of getting 
T2DM. Furthermore, we indicated that the prediabetes condition would arise at a minimum CPD of 20 
cigarettes and a minimum smoking duration of 25 years. While, the diabetes condition will appear at a 
minimum CPD of 20 cigarettes with a minimum smoking duration of 29 years (Patramurti and Fenty, 
2020). Based on the data presented in Table 1 above, it saw that 91.3% (17.4% smoked < 10 and 
93.9% smoked 11-20) of participants have only smoked less than 20 cigarettes per day.  However, 
87% of them have smoked for more than 25 years, but only 13% of them have had a smoking activity 
for less than 25 years. The participants who smoked less than 25 years have a family history of 
diabetes. Therefore, smoking activity would accelerate the development of T2DM on the subjects. 
Some other participants straight continue to smoke, although they have been diagnosed with T2DM 
and did not seem to care about the hazard of smoking on diabetes complications. Chang (2012) have 
reported that smoking could worsen the illness harder to manage and would increase the incurring 
some severe diabetes complications, including heart and kidney disease, retinopathy, peripheral 
neuropathy, heart disease, stroke, and circulation problems. 
Many diabetic patients continue to smoke despite the hazard of smoking on diabetes 
complications and mortality. Nicotine, the active compound in cigarettes, was considered as the most 
risk factor responsible for developing T2DM in smokers, both active and passive smokers. Nicotine 
can trigger insulin resistance and inhibit insulin secretion. According to  Bajaj (2012) and Bergman et 
al. (2012), the interaction of nicotine to nicotinic acetylcholine receptors (nAChRs) would activate the 
mammalian target of rapamycin (mTOR / p70S6) and would cause phosphorylation of insulin receptor 
substrate 1 (IRS-1 / Ser 636). So, the long term of cigarette smoke exposure in active and passive 
smokers would be increasing of IRS-1/Ser 636 phosphorylation and could be leading to impaired 
insulin receptors and develop insulin resistance. Another study has reported that the interaction of 
nicotine with nAChRs in β cells pancreas in the long term would cause the increased apoptosis of 
pancreatic β cells so the insulin production would be disrupted and resulting in high blood glucose 
levels (Morimoto et al., 2013). There has been estimating that approximately 80% of inhaled nicotine 
were inactivated into cotinine and trans-3-hydroxycotinine by the CYP2A6 enzyme coded by the 
CYP2A6 gene. This gene has a high polymorphism with the inactive allele gene was CYP2A6*4 that 
would be reducing enzyme activity and ultimately resulting in decreased nicotine metabolism. 
The CYP2A6 * 4 allele gene identification in this study was carried out by the PCR method 
using whole blood as material for DNA isolation. The forward and reverse primer used in this study 
have designed specifically anneal to CYP2A6*1 and CYP2A6*4 allele genes with a sequence located 
in exon 10643 to 10993 and produced an amplicon of 350 bp length. The forward primer could anneal 
to CYP2A6*1 and CYP2A6*4 allele genes. On the other hand, we used two types of reverse primer, 
the wild type reverse primer could only anneal to CYP2A6*1 and the mutant reverse primer could 
only anneal to CYP2A6*4. These two reverse primer have only one different nucleotide, therefore, the 
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Figure 1. CYP2A6*4 allele gene amplicon identified using agarose 1,5% and detected under UV 
transilluminator (M: Marker (100 bp+3K); B: Blank; 1-3: CYP2A6*1 Amplicon; 4-6: 
CYP2A6*4 Amplicon) 
 
The following table has described the CYP2A6*4 allele gene frequency identified among the 
subjects who have participated in the study. 
 
Table 2. Genotype dan CYP2A6*4 allele frequency among participants 
Genotype 
Frequence  
Total Number of Participant (n=46) 
Non smokers (23) Smokers (23) 
CYP2A6*1/CYP2A6*1 56.52% (13) 30.13 (9) 47.83 (22) 
CYP2A6*1/CYP2A6*4 34.78% (8) 47.83% (11) 41.30% (19) 
CYP2A6*4/CYP2A6*4 8.70% (2) 13.04% (3) 10.87% (5) 
Allele Number of Allele (n=92)   
CYP2A6*1  36.96% (34) 33.70% (31) 57.61% (65) 
CYP2A6*4  13.04% (12) 16.30% (15) 42.39% (27) 
 
As described in Table 2, it appears that the CYP2A6*4 alleles frequency among the participants 
is 42.39%. All of the subjects who participated in this study are Javanese, so this result was consistent 
with our previous studies that were resulted in the allele frequency of the CYP2A6*4 among Javanese 
smokers was high (Patramurti et al., 2015). Tanner and Tyndale (2017) have also noticed that among 
Asian populations, the allele frequencies of an inactive CYP2A6 gene were higher compared to 
Caucasians. According to Mwenifumbo et al. (2008), smokers with the CYP2A6*4 allele gene have 
been considering as poor or slow metabolizers. Therefore, nicotine metabolism in a smoker who has 
the CYP2A6*4 gene allele would be slower compared to normal/fast metabolizers. Thus, CYP2A6 
slow metabolism is associated with decreased nicotine metabolism and increasing the nicotine plasma 
level. Liu et al. (2011) have reported that slow or poor metabolizer smokers would have been more 
susceptible to suffering T2DM compared with fast or intermediate metabolizer smokers.  
All the participants who are smokers in this study have been smoking cigarettes for more than 
20 years. Therefore, all of them have been exposing to nicotine for a long time. The other that all the 
participants, both active and passive smokers, are adult and elder, with the average age is 54 years. So, 
all of the participants have been exposing to cigarette smoke for a long time. Maddatu et al., (2017) 
have described that in a cohort study among females who are never smoke, exposure to secondhand 
smoke may be a risk factor for the development of T2DM. The exposure to nicotine in the long term in 
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T2DM. It was mainly for slow metabolizers, both in active and passive smokers, due to the pancreas 
exposed to greater circulating levels of nicotine that may contribute to apoptosis of islet β-cells and 
causing the decreasing insulin.   
Another potential mechanism that was underlying the development of T2DM among smokers, 
both active and passive smoker, related to the CYP2A6*4 allele gene, was a tobacco-specific 
nitrosamine (TSNA) contained in cigarette smokers. There are some TSNA, pre-carcinogen 
compounds contained in both smoked and smokeless tobacco products, including 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N-Nitrosonornicotine (NNN),  
nitrosaminoaldehyde (NNAL), N-nitrosoanatabine (NAT) (Sugiyama et al., 2012; Wang et al., 2012; 
Yalcin and de la Monte, 2017). These compounds were metabolically activated to carcinogens by 
CYP2A6 in the liver or CYP2E1 expressed in pancreatic islets (Chowdhury et al., 2010; Kushida et 
al., 2000; Yuan et al., 2017). Thus, for people with CYP2A6 slow or poor metabolizing genotype, the 
hepatic first-pass metabolism of these compounds would decrease, resulting in higher systemic levels 
and greater exposure of these compounds in the pancreas islet. The enhancement levels of these 
compounds in pancreatic islet cells could be leading to metabolic activation by CYP2E1 and 
furthermore could lead to the development of pancreatic inflammation and apoptosis of insulin-
secreting cells (Lees et al., 2004), finally, it would decrease the insulin secretion and the increased risk 
of development T2DM.   
It was the first study to establish an association between the CYP2A6*4 allele gene among 
Javanese Indonesian T2DM patients, both active and passive smokers.  This study is in line with other 
studies that reveal smoking as a modifiable and independent risk factor for T2DM, and the presence of 
the CYP2A6 * 4 allele gene in a person would increase the risk for developing of T2DM (Eze et al., 
2014; Hackethal, 2015; Liu et al., 2011; Maddatu et al., 2017) . The other CYP2A6 allele gene that 
was common in Asia that was could decrease CYP2A6 activity was the CYP2A6*7 and CYP2A6*9 
allele gene. Therefore, although in this study the CYP2A6*4 allele gene has not been identified in 
some non-smokers participants and the participant who has not a family history of DM, these 
participants may have the CYP2A6*7 or CYP2A6*9 allele gene. In future studies, it is necessary to 
identify these two alleles in T2DM patients. 
According to Morimoto et al. (2013), Asians have a low ability to secrete insulin, so the results 
of this study may also be crucial for other Asian populations in reducing the development of T2DM. 
International Diabetes Federation has revealed that Indonesia was leading in the sixth country with the 
highest burden of diabetes mellitus in the world, there were saw that more than 10 million Indonesians 
had been suffering diabetes in 2017. The World Health Organization (WHO) has even predicted that 
more than 21 million Indonesians will develop diabetes by 2030. Primary Health Research Indonesia 
have reported that the prevalence of diabetes mellitus among Indonesia's adult population was 6.9% in 
2013 and ascended to 8.5% in 2018. Therefore, diabetes prevention and control were needed to reduce 
the incidence of diabetes mellitus and prevent its complications.  
Unlike type 1 diabetes, there is currently no known way to prevent it. The development of 
T2DM in people with high risk could be prevented or delayed. Some studies have established that 
lifestyle modification, including quit smoking, can prevent or delay the onset of T2DM. Bergman et al. 
(2012) have revealed that insulin sensitivity to glucose will be returning to normal in a smoker who 
has stopped smoking. Some other studies have also reported that quitting smoking has been appeared 
to decrease the T2DM risk over time. It seems that the most important thing individuals living with 
T2DM could do to delay the onset of complications (Cho et al., 2009; Luo et al., 2013; Nilsson et al., 
2014).  
The CYP2A6 allele gene of smokers would affect whether a smoker would be easy to quit 
smoking or not. Some research has shown that smokers who have inactive alleles, especially 
CYP2A6*4, tend to be easier to stop smoking.  It is due to their incapability to metabolize nicotine 
into cotinine (Ando et al., 2003; Fujieda et al., 2004; Minematsu et al., 2006). The other studies 
reported that the number of CPD of smokers who had a heterozygote genotype, including  CYP2A6 * 
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4, CYP2A6 * 7, CYP2A6 * 9, and CYP2A6 * 10 alleles were less than subjects who had a 
homozygous genotype (CYP2A6 *1/*1) (Chenoweth et al., 2013; O’Loughlin, 2004; Schoedel et al.,  
2004). According to our study, Javanese Indonesians have been categorizing as slow or poor 
metabolizers due to their belonging CYP2A6*4 allele gene, so they might be easier to stop their 
smoking. Therefore, the smoking cessation program should be encouraged for diabetes control and the 
prevention of diabetic complications among this population. 
According to Padmawati et al. (2009), as many as 65% of  T2DM patients in Yogyakarta 
Special Region had a smoking history, even though some T2DM patients have continued to smoke 
without caring about the diabetic complication that will be occurring. It is due to that there was no 
integrated effort from health-care providers in Indonesia to encourage the smoking cessation program. 
Other than that, the smoking cessation program was not a routine part of diabetes counseling despite 
the risk of smoking to those with diabetes. Based on our study, we concluded that reducing the high 
smoking rate in Indonesia must be the principal goal of public health to prevent and control diabetes 
development, especially T2DM and its complications. 
The Indonesian Consumers Foundation has stated that the non-smoking area was certainly 
needed to protect people from cigarette smoke so that they will not become passive smokers. 
Government Regulation of the Republic of Indonesia No. 188/Menkes/Pb/I/2011 and Number 7 of 
2011 regarding The Guidelines Implementation of No-Smoking Areas was one of the government's 
efforts to reduce the air pollution caused by cigarette smoke. Through the application of this 
regulation, it has been expecting that the number of smokers in Indonesia would decrease, so that it 
would have an impact on reducing the number of diseases caused by cigarette smoke, including 
T2DM, both active and passive smokers. The no-smoking areas applied to the public facility, such as 
schools, work environments, community services, and public transportation areas, was one of the 
strategies that contribute to everyone's health. Yogyakarta Special Region was one of the provinces 
that have implemented this regulation in almost 80% of its regions, including Sleman. Furthermore, 
they also have had promotive and preventive programs through ongoing education of the smoking 
impact on children and adolescents in their school. The Environmental improvements and healthier 
behavior-changing are also carried out and planned systematically by all community components, such 
as the Healthy Living Community Movement (known as Gerakan Masyarakat Hidup Sehat/GERMAS) 
and Integrated Service Center (known as Pos Pembinaan Terpadu/POSBINDU), to realizing a better 
degree of public health. In these public centers, health screening has also early carried out to detect the 
behavioral risk factors that caused some non-communicable disease, including diabetes. 
Unfortunately, until now, there are not many people using this health facility, therefore the diabetes 




It was a cross-sectional study. The smoking status information has just determined on self- 
assessment from the subject. Furthermore, there were not biological validation methods to confirm and 
report the smoking status, including expired air carbon monoxide or saliva/plasma/urine cotinine 
concentrations. In this study, there were also confounding factors that have not been anticipating, 
given the possible link between smoking and alcohol consumption, and drinking coffee that might also 
influence glucose blood levels. 
 
CONCLUSIONS 
From this study, we define that smoking would increase the potential development for suffering 
T2DM, neither active nor passive smokers. We have also described that the CYP2A6*4 high 
frequency has been founding among Javanese Indonesian T2DM patients causing they have more 
easily get T2DM. Thus, the principal strategies for reducing the number of diabetes incidences, neither 
active nor passive smokers, and preventing the development of diabetes complications were educating 
the people to quit smoking and encourage smoking cessation programs.  
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